We offer private and public equity financing designed to meet the unique needs of your health care company – capital for growth, shareholder liquidity, growth recapitalizations, leveraged buyouts, spin-off transactions, PIPEs, debt restructurings, and acquisition financings.
In 2006, we raised GPP I, a $156 million lower middle market buyout fund. In 2013, we raised GPP II, a $215 million lower middle market fund which continues the same strategy as GPP I. In 2003, we started our health care public fund (Biomedical Value Fund). Together these funds manage approximately $900 million.
Private equity investments of $7 million to $25 million in growing companies.
Learn more about GPP I, II.
Public equity structured investments (PIPEs) and open market purchases of $10 to $50 million. Learn more about BMVF.